ImageneBio (IMA) Shares Outstanding (Weighted Average) (2020 - 2025)

ImageneBio has disclosed Shares Outstanding (Weighted Average) across 6 years of filings, most recently posting $530714.0 for Q4 2025.

• Shares Outstanding (Weighted Average) for Q4 2025 came in at $530714.0, down 98.9% year-over-year; the trailing twelve-month figure through Dec 2025 was $530714.0 (down 98.9% YoY), and the FY2025 annual result was $530714.0, down 98.9% from the prior year.
• Shares Outstanding (Weighted Average) came in at $530714.0 for Q4 2025 at ImageneBio, down from $8.5 million in the prior quarter.
• In the past five years, Shares Outstanding (Weighted Average) ranged from a high of $48.3 million in Q1 2024 to a low of $530714.0 in Q4 2025.
• The 5-year median for Shares Outstanding (Weighted Average) is $36.2 million (2022), against an average of $29.8 million.
• Across the five-year window, Shares Outstanding (Weighted Average) jumped 1248.76% in 2021 and slumped 98.9% in 2025, its largest moves.
• ImageneBio's Shares Outstanding (Weighted Average) stood at $28.0 million in 2021, then gained by 29.32% to $36.2 million in 2022, then advanced by 15.33% to $41.7 million in 2023, then grew by 15.63% to $48.3 million in 2024, then plunged by 98.9% to $530714.0 in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $530714.0 (Q4 2025), $8.5 million (Q3 2025), and $48.3 million (Q2 2025), per Business Quant data.